BRCA Testing & PARP Inhibitors in Breast Cancer

Oncology Clinical News

CMS Starts to Cover Broad Cancer DNA Tests, Boosting Foundation, Thermo

(Xconomy Boston) Mar 19, 2018 - The Centers for Medicare & Medicaid Services, which administers the federal Medicare insurance program, will begin covering FDA-approved diagnostic tests that scan tumors for a range of genetic mutations.
Read full article.

Powered by OBR Oncology